AstraZeneca Results Presentation Deck
Drug development
digital synthetic route design
AI in Global Operations
Leveraging the power of AI throughout our end-to-end supply chain
in-silico models
50% reduction in
route design lead time with
Al-enabled predictive tools
Solving for
optimised
routes with:
CEO Opening Remarks
Fewest synthetic steps
Lowest potential COGS
Lowest carbon footprint
GLOBAL OPERATIONS | drug development, manufacturing and supply chain powered by Al
Supply chain
digital twins for raw material planning
13 1. In Gärtuna, Sweden. CMC - Chemistry, Manufacturing and Controls.
Al = artificial intelligence; COGS = cost of goods sold.
Financial Results
Manufacturing
advanced analytics and optimisation
Identify new
parameters
>>>>
O
O
Oncology
<<<<
<<<<
>20% increased yield
with Al-enabled analytic tools
Target process
adjustments
BioPharmaceuticals
Define new
process ranges
Rare Disease
1 |
2
90% reduction in
dispensing planning time
with Al-enabled digital twins
CEO Closing Remarks
balance material, asset,
resource availability
balance for various
operations and products
while ensuring
"just-in-time"
processView entire presentation